About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 702 record(s)
Req # A-2021-001573
Adverse Drug Reactions (ADRs). Report Numbers: E2B_03501912, 000939696, E2B_03712652, E2B_03942773, E2B_04064806, E2B_03887066, E2B_03614172.Organization: Health Canada
March 2022
Req # A-2021-001587
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report Number: E2B_03554038, E2B_03700252, E2B_03527438, E2B_03562188, E2B_03618565, E2B_03632444, E2B_03807264, E2B_0377742, E2B_03764367, E2B_03658288, E2B_03900718, E2B_03841039, E2B_03841485,…Organization: Health Canada
March 2022
Req # A-2021-001591
Adverse Drug Reactions (ADRs) for TRIAMCINOLONE ACETONIDE. Report Numbers: E2B_04613296, E2B_04574667.Organization: Health Canada
March 2022
Req # A-2021-001616
Adverse Drug Reaction (ADR) for VANDETANIB. Report Number: E2B_04386015.Organization: Health Canada
March 2022
Req # A-2021-001617
Adverse Drug Reactions (ADRs) for CROMOGLICATE SODIUM. Report Numbers: 000957351, E2B_04313988.Organization: Health Canada
March 2022
Req # A-2021-001622
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report Numbers: 962609, 962696, 960955, E2B_04331117, E2B_04134135, E2B_04331668, E2B_04174471, E2B_04381193, E2B_04370622.Organization: Health Canada
March 2022
Req # A-2021-001631
Adverse Drug Reactions (ADRs) for MMR II. Report Numbers: E2B_02311198, 000720772, E2B_02307576, E2B_02306421, E2B_02311283, 000616948, 000624117, E2B_00235106, 000628633, 000716559.Organization: Health Canada
March 2022
Req # A-2021-001635
Adverse Drug Reactions (ADRs) for Abilify. Report numbers: 966470, E2B_04377827, E2B_04411181, E2B_04411619, E2B_04392143, E2B_04410041, 960155, 960491, E2B_04463409, E2B_04463456, E2B_04463478, E2B_04612196, E2B_04470497, E2B_04470794. ADRs for…Organization: Health Canada
March 2022
Req # A-2021-001636
Adverse Drug Reactions (ADRs) for Aripiprazole. Report numbers: 964316, 964509, 970042, 958431, 961466, E2B_04452312, E2B_04472034. ADR for Inqovi. Report number: 965240. ADRs for Patiromer. Report numbers: E2B_04457129, E2B_04503217, E2B_04549768.…Organization: Health Canada
March 2022
Req # A-2021-001638
Adverse Drug Reactions (ADRs) for HYOSCINE BUTYLBROMIDE. Report numbers: E2B_04405771, E2B_04331204.Organization: Health Canada
March 2022